Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1891 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Biolaxy Receives IND Approval For Nodlin In China

The Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for Biolaxy’s oral insulin project (Nodlin), an innovative insulin formulation to treat

Astellas To Install PAS-X At Meppel

Astellas will install PAS-X at its production site in Meppel. PAS-X is an EBR (Electronic Batch Recording). PAS-X will be installed at the company’s pharmaceutical solids production and